Literature DB >> 30873588

Regulatory roles of long noncoding RNAs implicated in cancer hallmarks.

Jun Wang1,2, Xuan Zhang1,3, Wen Chen1,4, Xiang Hu4, Jing Li1, Changning Liu1,4.   

Abstract

Cancer cells acquire numerous biological properties (designated "cancer hallmarks"), such as cell survival and energy metabolism, that facilitate tumor growth and metastatic dissemination during development. To date, eight hallmarks of cancer have been identified that provide a logical framework for understanding the remarkable diversity of neoplastic diseases, as proposed by Douglas Hanahan and Robert A. Weinberg. Long noncoding RNAs (lncRNAs), a category of transcripts widely demonstrated to exert significant regulatory effects on biological processes, have attracted considerable research attention due to their association with the occurrence and development of cancer. The mechanisms by which lncRNAs exert their functions require elucidation to optimize their potential utility as alternative biomarkers and therapeutic targets during tumor occurrence and progression. In this review, we have discussed recent research progress on lncRNAs involved in various cancer hallmarks and their related mechanisms of action, with a view to providing an updated picture of their immense therapeutic potential in the fight against cancer.
© 2019 UICC.

Entities:  

Keywords:  cancer hallmarks; lncRNA

Mesh:

Substances:

Year:  2019        PMID: 30873588     DOI: 10.1002/ijc.32277

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  XIST promote the proliferation and migration of non-small cell lung cancer cells via sponging miR-16 and regulating CDK8 expression.

Authors:  Xiaoyun Zhou; Xiaohui Xu; Chao Gao; Yushang Cui
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  Long non-coding RNA SOS1-IT1 promotes endometrial cancer progression by regulating hypoxia signaling pathway.

Authors:  Hongyang Liu; Junhu Wan; Quanling Feng; Jingyu Li; Jun Liu; Shihong Cui
Journal:  J Cell Commun Signal       Date:  2021-10-12       Impact factor: 5.908

3.  Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors.

Authors:  Olga Y Burenina; Natalia L Lazarevich; Inna F Kustova; Daria A Shavochkina; Ekaterina A Moroz; Nikolay E Kudashkin; Yuriy I Patyutko; Alexey V Metelin; Eduard F Kim; Dmitry A Skvortsov; Timofei S Zatsepin; Maria P Rubtsova; Olga A Dontsova
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-12       Impact factor: 4.553

4.  Suppression of circulating AP001429.1 long non-coding RNA in obese patients with breast cancer.

Authors:  Hani Choudhry; Mohammed A Hassan; Abdulrahman L Al-Malki; Kaltoom A Al-Sakkaf
Journal:  Oncol Lett       Date:  2021-05-03       Impact factor: 2.967

Review 5.  The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.

Authors:  Abdelhakim Bouyahya; Hamza Mechchate; Loubna Oumeslakht; Ikrame Zeouk; Sara Aboulaghras; Abdelaali Balahbib; Gokhan Zengin; Mohammad Amjad Kamal; Monica Gallo; Domenico Montesano; Nasreddine El Omari
Journal:  Biomolecules       Date:  2022-02-25

Review 6.  The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.

Authors:  Yongcan Xu; Mantang Qiu; Minmin Shen; Shunli Dong; Guochao Ye; Xuefei Shi; Ming Sun
Journal:  Mol Ther       Date:  2021-03-26       Impact factor: 12.910

7.  Circular RNA ITCH suppresses proliferation, invasion, and glycolysis of ovarian cancer cells by up-regulating CDH1 via sponging miR-106a.

Authors:  Chunli Lin; Xiaofeng Xu; Qiumin Yang; Lu Liang; Shulin Qiao
Journal:  Cancer Cell Int       Date:  2020-07-23       Impact factor: 5.722

8.  lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1.

Authors:  Jing Luo; Huishan Wang; Li Wang; Gaoming Wang; Yu Yao; Kai Xie; Xiaokun Li; Lin Xu; Yi Shen; Binhui Ren
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-01       Impact factor: 8.886

9.  Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma.

Authors:  Ying Xing; Xianhua Sun; Feng Li; Xuan Jiang; Afang Jiang; Xiaofan Li; Ruiting Lv; Liwei Shao
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

10.  Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1.

Authors:  Li Tang; Da Wei; Xinyu Xu; Xuelian Mao; Dongping Mo; Linping Yan; Weiguo Xu; Feng Yan
Journal:  NPJ Breast Cancer       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.